Glycogen Flashcards
Liver glycogen stores
- Glycogen is stored in the fed state to maintain blood glucose when needed
- Depleted during a fasted state after 12-18 hours
Glycogen
- Glycogenin protein w/ alpha 1,4 glucose chains and alpha-1,6 branch points
- Glycogenin serves as a primer by glucosylating itself (autoglucosylation). That is, glycogenin via a –OH groups of tyrosine within its structure makes a bond to a glucose. The glucose on glycogenin then further elongates the polysaccharide chain
- The anomeric carbon that is not attached to another glycosyl residue (the reducing end) is attached to the protein glycogenin by a glycosidic bond via the amino acid tyrosine.
Muscle glycogen stores
- Glycogen is stored to provide energy during prolonged exercise
- Not affected by short periods of fasting (a few days) and moderately depleted in prolonged fasting (weeks)
Glycogen synthase
- transfers the glucose in UDP glucose to one of the growing glycogen branches forming α-1,4 linkages
- G6P allosterically partially activates the inactive (phosphorylated) form of glycogen synthase.
- If glucose levels ⬆️⬆️ in the cell and glycolysis/TCA is going at top speed, but not keeping up with demand, G6P levels⬆️; backup occurs at glycogen synthase
Branching enzyme, 4:6 transferase
- When about 11 glucose molecules are added to one growing chain of glycogen this enzyme moves a chain of 6-8 glucose molecules to form a new branch chain starting with an α-1,6 linkage at the branch
Glycogen Storage Disease Type 0 (GSD 0) molecular basis
- A deficiency in the enzyme glycogen synthase results in very low amounts of glycogen stored in the liver. A person between meals can develop hypoglycemia
Glycogen Storage Disease Type 0 (GSD 0) symptoms
- drowsiness, vomiting, fatigue and sometimes convulsions, and look pale
- muscle cramps from accumulated lactic acid
- mild growth delay
Glycogen Storage Disease Type 0 (GSD 0) diagnosis
- liver biopsy will show very little glycogen. DNA testing is available
Glycogen Storage Disease Type 0 (GSD 0) treatments
- snacks every 3-4 hours
- Uncooked cornstarch can act as a ‘slow release’ form of glucose and may prevent hypoglycemia overnight
- A diet higher than normal in protein may help with the cramping, tiredness and fatigue
- affects both males and females
Andersen disease (GSD IV) molecular basis
- Deficient activity of the glycogen-branching enzyme
- accumulation of abnormal glycogen in the liver, muscle and other tissues
- autosomal recessive
Andersen disease (GSD IV) symptoms
- In the perinatal variant usually symptoms become apparent in the first few months of a baby’s life
- failure to thrive - slow growth and failure to gain weight at the expected rate
- abnormally enlarged liver and spleen
- progressive liver scarring and liver failure
Andersen disease (GSD IV) treatment
- very severe but rare disorder
- liver transplantation
- Most children with this condition die before two years of age
Adult Polyglucosan Body Disease (APBD) molecular basis
- deficient glycogen- branching enzyme activity, diffuse CNS and peripheral nervous system dysfunction
Major principles of metabolic regulation
- Maximize the efficiency of fuel utilization by preventing the simultaneous operation of opposing pathways (i.e., futile cycles).
- Partition metabolites appropriately between alternative pathways.
- Draw on the fuel best suited for the immediate needs of the organism.
- Shut down biosynthetic pathways when their products accumulate.
What are the physiological effects of insulin on the cell?
- a phosphatase removes a phosphate group on the enzymes and proteins in cells (Covalent modification by dephosphorylation)
- Insulin, via an insulin factor, activates phosphatases to remove phosphate groups from glycogen phosphorylase, thus INACTIVATING glycogen breakdown
- Insulin, via an insulin factor, activates phosphatases to remove phosphate groups from glycogen synthase, thus ACTIVATING glycogen synthesis
- stimulates the uptake of glucose by muscle (Glut-4)
- When ↑glucose, ↑insulin, ↓glucagon, phosphatases are active
- stimulates glycogen synthesis
Glycogen phosphorylase
- removes one glucose molecule at a time and converts it to glucose-1-P
- cannot remove glucose within 4 residues of a branch point (α-1,6 linkage)
Debranching enzyme
2 independent active sites catalyzing transferase and glucosidase reactions:
- 4:4 transferase activity
- glucosyl transferase
- removes the three glucose residues (as a trisaccharide) adjacent to the branch point (the α-1,6 linkage) and transfers them to the end of another row
- 4:4 transferase because the enzyme breaks an α−1,4 bond and forms
another α−1,4 bond
- 1:6 glucosidase activity
- α-1,6-glucosidase or amylo-6-glucosidase
- removes the α-1,6 glucosidic bond to release one glucose molecule as glucose
Lysosomal degradation of glycogen
- Approximately1-3% of glycogen is degraded by lysosomal enzyme α(1→ 4)- glucosidase
- involved in debranching and hydrolysis of both α-1,4- and α-1,6-glucosidic linkages at acidic PH of 5 and necessary to break down glycogen
Glycogen Storage Disease (GSD) generalities
- genetic disorders characterized by accumulation of abnormal amounts of glycogen primarily due to decreased degradation
- Synthesis of glycogen occurs in liver and muscle (also minor storage in kidney and intestine) so the GSDs have their primary effect on liver, muscle, RBC, or all
Pompe disease (GSD II) molecular basis
- deficiency of α(1→ 4) glucosidase or α-1,6-glucosidase or acid maltase
- deficiency in this enzyme results in accumulation of excess amounts of glycogen (normal structure)